Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images. #ACC20 #ACC2020

Closing access to the radial artery after harvesting a section of the artery for a coronary artery bypass graft (CABG). Photo by Getty Images.

News | Cardiovascular Surgery | March 30, 2020

March 30, 2020 — Patients undergoing coronary bypass graft (CAGB) surgery lived longer and had better outcomes when...

Conclusions from the TAVR vs surgery trial for aortic valve replacement in the U.K. presented by William D. Toff, M.D. at ACC 20. #ACC20 #ACC2020 #TAVR #TAVR

Conclusions from the real world TAVR vs. surgery trial for aortic valve replacement outcomes in the U.K., presented by William D. Toff, M.D. at ACC 20. 

News | Heart Valve Technology | March 30, 2020

March 30, 2020 — Patients in the United Kingdom (U.K.) who underwent transcatheter aortic valve replacement (TAVR)...

PARTNER 3 trial shows positive results for Sapien 3 in low-risk surgical patients. #ACC20 #ACC2020 #Sapien3 #TAVR
Feature | Heart Valve Technology | March 30, 2020

March 30, 2020 — Patients undergoing transcatheter aortic valve repair (TAVR) low-risk patients at two years did...

News | Heart Valve Technology | March 29, 2020

March 29, 2020 — Worse than expected outcomes were found for survival and quality of life among patients undergoing...

Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve replacement (TAVR) procedures had a high rate of success and low risk of death or disabling stroke at 30 days, according to new data presented at the American College of Cardiology (ACC) 2020 Scientific Session. #ACC20 #ACC2020
Feature | Heart Valve Technology | March 29, 2020 | Dave Fornell, Editor

March 29, 2020 — Patients with bicuspid, or two-leaflet, aortic valves who undergo transcatheter aortic valve...

Medicare, CMS, calls for cancelling or postponing all elective or non-essential medical procedures, test and surgeries due to COVID-19. #COVID19 #SARcov2 #coronavirus #cardiology
Feature | Coronavirus (COVID-19) | March 20, 2020 | Dave Fornell, Editor
News | Artificial Heart | March 10, 2020

March 10, 2020 —  The U.S. Food and Drug Administration (FDA) has cleared the SynCardia Systems 50cc temporary Total...

ACC issues document outlining COVID-19 Implications For Patients With Underlying Cardiovascular Conditions. The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate. #COVID19 #coronavirus #2019nCoV #SARS‐CoV‐2

The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate.

Feature | Coronavirus (COVID-19) | March 09, 2020

March 9, 2020 — The American College of Cardiology (ACC) is...

News | Heart Failure | March 05, 2020

March 5, 2020 — Abbott recently received Breakthrough Device designation from the U.S. Food and Drug Administration...

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.

News | Cardiovascular Surgery | February 27, 2020

February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare...

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI

A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Image courtesy of TeraRecon

Feature | Heart Valve Technology | February 24, 2020 | Dave Fornell, Editor

In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter...

he U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device exemption (IDE) application to start a U.S. early feasibility study (EFS) of its total artificial heart.
News | Heart Failure | February 12, 2020

February 12, 2020 — The U.S. Food and Drug Administration (FDA) has approved Carmat's investigational device...

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive heart valve replacement to open-heart surgery. Photo by Cedars-Sinai. TAVR performs as well as surgery for aortic valve replacement.

Raj Makkar, M.D., led a multicenter national study comparing outcomes for minimally invasive TAVR heart valve replacement to open-heart surgery. The study showed the two methods have similar outcomes. Photo by Cedars-Sinai.

News | Heart Valve Technology | January 31, 2020

January 31, 2020 — A new study from the ...

Mayo Clinic uses the Da Vinci surgical robot to perform minimally invasive mitral valve surgeries.
News | Robotic Systems | January 20, 2020

January 20, 2020 — Research has found that repairing the mitral valve earlier, before the mitral valve prolapse...

Overlay Init